For research use only. Not for therapeutic Use.
Cyclovirobuxine D is an active compound extracted from Buxus microphylla, which has been used for treating acute myocardial ischemia.<br>Cyclovirobuxine D increases cardiomyocytes viability injured by oxidation or hypoxia. It significantly reduces the infarct size induced by ligating the coronary artery in rats. In addition, Cyclovirobuxine D protects rat aorta endothelial cells against hypoxia and enhanced nitric oxide (NO) release from endothelial cells.<br>Cyclovirobuxine D decreases the weight of venous thrombus in rats.
| Catalog Number | R024216 |
| CAS Number | 860-79-7 |
| Synonyms | 4,4,14-Trimethyl-3β,20α-bis(methylamino)- 9,19-Cyclo-5α,9β-pregnan-16α-ol; ?1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene 9,19-Cyclopregnan-16-ol deriv.?(3α,5α,16α,20S)-4,4,14-Trimethyl-3,20-bis(methylamino)-9,19-cyclopregnan-16-ol?Bebuxine; CVB-D |
| Molecular Formula | C26H46N2O |
| Purity | ≥95% |
| Target | Autophagy |
| Storage | 3 years -20C powder |
